-
Mashup Score: 22Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody - 1 month(s) ago
Monoclonal immunoglobulin deposition disease (MIDD) is characterized by deposits of intact monoclonal immunoglobulin protein, most commonly in the kidney, but other organs such as the heart can be in…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 42
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw
-
-
Mashup Score: 1
Podcast Episode · Blood Cancer Talks · 03/14/2024 · 47m
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet-
@dgermain21 Well said David! I think too much careerism is a source of burnout. In this regard, Dr, Tefferi shared some profound wisdom in one of our @BloodCancerTalk episode! https://t.co/1qWVJfRRzr
-
-
Mashup Score: 16Paper: Development of Anti-Amyloid 11-1F4- CAR Phagocytes for Treatment of AL Amyloidosis - 3 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Understanding and Improving TCE and CAR-T Cell Therapies for Plasma Cell Disorders Hematology Disease Topics & Pathways: Research, Fundamental Science, Translational Research Jing Fu, PhD 1, Huihui Ma, PhD, MD 2 *, Shirong Li, PhD 1, Michael Sang Hughes, MD 3, Gavreel Kalantarov, PhD 1 *, Guifen Liu, MS 1 *, Markus Mapara, MD, PhD 2 * and Suzanne Lentzsch, MD, PhD 4 1 Department
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet-
Intriguing pre-clinical data from @SLentzsch lab @columbiacancer on CAR-modified macrophages targeting 11-1F4 on amyloid fibrils➡️Increased amyloid clearance in vitro and in vivo using humanized AL amyloidosis mouse model! #ASH24 https://t.co/3kp04LpGqH
-
-
Mashup Score: 51
Although sudden death (SD) is a recognized complication of cardiac amyloidosis, there is scarce data about its incidence, mechanisms, and predictors. The aim of this study was to describe incidence…
Source: www.tandfonline.comCategories: General Medicine News, Partners & KOLsTweet-
Sudden Death in AL Cardiac Amyloidosis: ~8% at a median f/u of 1.2 years (most in 1st 6 months) Most common event: PEA 80% during sleeping or resting (not with activity) Beta-blocker use associated with ~7x risk on MVA https://t.co/oZx0q6081L https://t.co/SycLazOsQz https://t.co/COKoJ5XLnQ
-
-
Mashup Score: 8Support my Velocity fundraiser and help Columbia solve cancer. - 5 month(s) ago
On October 6, I’ll be participating in Velocity. I’ve committed to raising crucial funds to help solve cancer at Columbia’s Herbert Irving Comprehensive Cancer Center and I can’t do it without you. Will you support me with a donation today?
Source: www.velocityride.orgCategories: General Medicine News, Partners & KOLsTweet-
🚴♂️Join us for @columbiacancer Velocity Ride and help support our #Myeloma and #Amyoidosis research! @SLentzsch @DivayaB @CAMPamyloidosis https://t.co/niLQBYlXO1 https://t.co/r5XBYl1rH5
-
-
Mashup Score: 42
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw
-
-
Mashup Score: 13
The Glasgow prognostic score (GPS) and CAR-HEMATOTOX (CAR-HT) score identify multiple myeloma (MM) patients at high risk for immune-mediated toxicity and early mortality with cellular immunotherapy. …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet-
RT @MeeraMohanMD: British Journal of Haematology | Wiley Online Library https://t.co/54ZO37zYyz Can baseline GPS (CRP, albumin) and CART H…
-
-
Mashup Score: 10
The Glasgow prognostic score (GPS) and CAR-HEMATOTOX (CAR-HT) score identify multiple myeloma (MM) patients at high risk for immune-mediated toxicity and early mortality with cellular immunotherapy. …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet-
RT @MeeraMohanMD: British Journal of Haematology | Wiley Online Library https://t.co/54ZO37zYyz Can baseline GPS (CRP, albumin) and CART H…
-
-
Mashup Score: 28MHG India - 7 month(s) ago
Medical HTML Template
Source: mhgindia.comCategories: General Medicine News, Partners & KOLsTweet-
Excited to join the Mumbai Hematology Group (https://t.co/JYQkTLfUcQ) today for a virtual talk on Bispecific Antibodies in the management of #MultipleMyeloma and AL #Amyloidosis! Link for joining: https://t.co/cZjWA0MZTH #mmsm https://t.co/LkpDPDxCvE
-
Brisk hematologic and cardiac organ response in a patient with Cardiac Monoclonal Immunoglobulin Deposition Disease treated with elranatamab! https://t.co/PVjxyGisqd @DivayaB @SLentzsch @columbiacancer @CU_Cardiology https://t.co/7NXnlaYu3w https://t.co/E5DeezG9tF